High-dose immunoglobulin pulse therapy and risk of Covid19 infection

Ítems similars

• Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)
  per: Dubbioso, Raffaele, et al.
  Publicat: (2020)
• Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
  per: Garnero, Martina, et al.
  Publicat: (2018)
• The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical rehabilitation: the value of telerehabilitation for evaluation and continuing treatment
  per: Prada, Valeria, et al.
  Publicat: (2020)
• People with Charcot-Marie-Tooth disease and COVID-19: Impaired physical conditions due to the lockdown. An International cross-sectional survey
  per: Prada, Valeria, et al.
  Publicat: (2020)
• Remarkable Rituximab Response on Tremor Related to Acute‐Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient
  per: Demichelis, Chiara, et al.
  Publicat: (2018)